Leonardo DRS, Inc. DRS 深 滬
已收盤 05-08 16:00:00 美东时间
41.36
-0.080
-0.19%
華盛通- 最 高41.83
- 今 開41.71
- 成交量 92.50万股
- 最 低 40.895
- 昨 收 41.44
- 總市值 110.33亿
- 52周最高 49.04
- 市盈率 靜 39.98
- 換手率 0.35%
- 52周最低 32.34
- 委 比 61.09%
- 總股本 2.67亿
- 歷史最高 49.04
- 量 比 0.90
- 振 幅 2.26%
- 歷史最低 8.66
- 每 手 1
- 風險率 4.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
财报速睇 | Leonardo DRS 2026财年Q1营收8.46亿美元，同比增长5.9%；归母净利润0.62亿美元，同比增长24.0%
华盛资讯5月6日讯，Leonardo DRS公布2026财年Q1业绩，公司Q1营收8.46亿美元，同比增长5.9%，归母净利润0.62亿美元，同比增长24.0%。
05-06 06:46
Leonardo DRS declares $0.09 dividend
Leonardo DRS (DRS) declares $0.09/share quarterly dividend, in line with previous. Forward yield 0.91% Payable June 2; for shareholders of record May 19; ex-div May 19. See DRS Dividend Scorecard, Yie...
05-06 03:13
Full Transcript: Leonardo DRS Q1 2026 Earnings Call
Leonardo DRS (NASDAQ:DRS) released first-quarter financial results and hosted a...
05-05 23:06
Leonardo DRS shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 guidance.
Leonardo DRS shares are trading higher after the company reported better-than-e...
05-05 19:58
财报速睇 | Leonardo DRS 2026财年Q1营收8.46亿美元，同比增长5.9%；归母净利润0.62亿美元，同比增长24.0%
华盛资讯5月5日讯，Leonardo DRS公布2026财年Q1业绩，公司Q1营收8.46亿美元，同比增长5.9%，归母净利润0.62亿美元，同比增长24.0%。
05-05 19:51
Leonardo DRS Raises FY2026 Adj EPS Guidance from $1.20-$1.26 to $1.26-$1.30 vs $1.25 Est; Raises FY2026 Sales Guidance from $3.850B-$3.950B to $3.900B-$3.975B vs $3.906B Est
Leonardo DRS (NASDAQ:DRS) raises FY2026 Adj EPS guidance from $1.20-$1.26 to $1.26-$1.30 vs $1.25 analyst estimate. Raises FY2026 sales outlook from $3.850 billion-$3.950 billion to $3.900 billion-$3.975 billion vs
05-05 19:33
Leonardo DRS Q1 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $846.000M Beat $829.621M Estimate
Leonardo DRS (NASDAQ:DRS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.20 by 30 percent. This is a 30 percent increase over earnings of $0.20 per share from the same
05-05 19:31
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
美股盘后 | Astera Labs涨5.78%，韩国SK电信涨4.41%
Astera Labs涨5.78%；韩国SK电信涨4.41%；Credo Technology涨3.93%
04-21 06:10
